A Phase 2, Open-Label, Randomized Controlled Trial Evaluating Safety and Efficacy of Dose-Intensified Versus Standard Dosing Regimens of [ 177 Lu]Lu-PSMA-597 in mCRPC (OPTIMAL-PSMA)

Journal of Nuclear Medicine · Published 2026-07-30 · DOI 10.2967/jnumed.126.272714

Authors (11)

Sobia Khan, Nathan Papa, Takanori Hioki, Megan Crumbaker, Sze-Ting Lee, Andrew Weickhardt, Shikha Sharma, Shraddha Weir, Katharina Luckerath, Edmond Kwan, Louise Emmett

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Khan, S., Papa, N., Hioki, T., et al. (2026). A Phase 2, Open-Label, Randomized Controlled Trial Evaluating Safety and Efficacy of Dose-Intensified Versus Standard Dosing Regimens of [ 177 Lu]Lu-PSMA-597 in mCRPC (OPTIMAL-PSMA). Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.126.272714

Related articles